ACiD

one argument, seven steps

a theory of where chronic disease begins, told in seven steps.

this is research, not medical advice.
reading the piece…

the piece is below, unchanged by this page.

the cascade

tap a step · hold to let it fall
a stepthe loop it namesmillions affected

fleet-hosted/gallery/acid-cascade.html

the cascade · as the piece states it

    downstream · US figures as stated

    disease · statedcost/yrchart

    receipt · the piece's own terms

    verify · no trust in this page needed
    1. Chart.getChart('diseaseChart').data
    2. diff surfaces/fleet/acid-cascade.html surfaces/fleet-hosted/gallery/acid-cascade.html
    3. check each figure against a primary source; the piece names fields, not studies

    the whole argument

    ACiD — Artificial Chronic Inflammatory Disease

    The TERT-ECS-Telomere Disease Cascade | Upstream Medicine | bnature.social/BiGen v1.0

    90%+
    of Chronic Disease is Downstream of ACiD
    TERT
    Gene Dysfunction = Root Cause
    $317T
    Reversible with Upstream Medicine

    The Disease Cascade — How ACiD Creates 90%+ of Chronic Disease

    1
    ARTIFICIAL CAUSESPetrochemical pharmaceuticals, pesticides/herbicides, artificial food additives, fluoride, chlorine, gain-of-function agents, DNA/RNA interventions, environmental toxins, suppression of plant medicine
    ▼
    2
    OXIDATIVE STRESS + CHRONIC INFLAMMATIONArtificial causes create persistent oxidative damage and inflammatory cascades at the cellular level
    ▼
    3
    TERT GENE DYSFUNCTIONTelomerase Reverse Transcriptase (TERT) is suppressed. The enzyme that maintains telomere length is disabled by chronic oxidative stress and ECS deficiency
    ▼
    4
    ECS DYSFUNCTIONEndocannabinoid System loses homeostatic capacity. CB1/CB2 receptors downregulate. Anandamide and 2-AG levels drop. The body's master regulatory system fails
    ▼
    5
    ARTIFICIAL TELOMERE SHORTENINGWithout TERT/telomerase, telomeres shorten 2-5x faster than natural aging. Cells reach senescence prematurely. Senescent cells secrete inflammatory cytokines (SASP) creating a FEEDBACK LOOP
    ▼
    6
    CELLULAR SENESCENCE CASCADESASP (Senescence-Associated Secretory Phenotype) spreads inflammation to neighboring cells. Immune system overwhelmed. Tissue degradation accelerates
    ▼
    7
    90%+ OF CHRONIC DISEASE MANIFESTSCancer, heart disease, diabetes, obesity, Alzheimer's, autoimmune disorders, depression, chronic pain, COPD, kidney disease — all downstream of the same upstream cascade

    The Artificial Causes of ACiD

    💊
    Petro-Pharma
    Synthetic drugs suppress ECS function, cause oxidative stress, create dependency cycles. $1.4T/yr US pharma spending
    🫀
    Pesticides
    Glyphosate, organophosphates, neonicotinoids disrupt cellular metabolism and microbiome
    🍲
    Food Additives
    Artificial colors, preservatives, emulsifiers, seed oils drive systemic inflammation
    💧
    Fluoride
    Endocrine disruptor. Calcifies pineal gland. Interferes with enzymatic processes
    ⚠
    Chlorine
    Water disinfectant byproducts (THMs) are carcinogenic and inflammatory
    🫀
    Biological Agents
    Gain-of-function research, DNA/RNA interventions. May directly damage telomeres
    👀
    Microplastics
    Endocrine disruption, cellular damage, inflammatory trigger. Found in human blood
    ⚡
    Heavy Metals
    Mercury, lead, aluminum, cadmium. Directly damage DNA and telomeres
    🚫
    Plant Suppression
    Cannabis/hemp prohibition = ECS nutrient deficiency epidemic. The remedy is criminalized

    Diseases Downstream of ACiD — US Statistics

    Heart Disease
    $363B/yr30.3M adults
    Cancer
    $200B/yr1.9M new/yr
    Diabetes (T2)
    $327B/yr37.3M adults
    Obesity
    $173B/yr100M+ adults
    Alzheimer's
    $355B/yr6.5M adults
    Autoimmune
    $100B/yr24M adults
    Depression/Anxiety
    $210B/yr40M adults
    Chronic Pain
    $300B/yr50M adults
    COPD
    16M adults
    $50B/yr
    Kidney Disease
    37M adults
    $87B/yr
    TOTAL
    $14.11T/yr

    Telomere Science — TERT, ECS & The Aging Clock

    What are telomeres? Protective DNA-protein caps at chromosome ends. Each cell division shortens them by ~50-100 base pairs. When critically short, cells enter senescence or apoptosis.

    TERT Gene (Telomerase Reverse Transcriptase): Codes for telomerase, the enzyme that LENGTHENS telomeres. When TERT functions properly, telomeres are maintained. When TERT is suppressed (by oxidative stress, inflammation, ECS dysfunction), telomeres shorten artificially fast.

    The ECS-Telomere Connection: The Endocannabinoid System regulates inflammation, oxidative stress, and cellular homeostasis. ECS dysfunction directly accelerates telomere shortening. Restoring ECS function (via cannabinoid nutrition/RDI) may protect TERT expression and slow or reverse telomere attrition.

    The SASP Feedback Loop: Senescent cells (from short telomeres) secrete pro-inflammatory cytokines (SASP). This inflammation causes MORE telomere shortening in neighboring cells. This is why chronic disease compounds and accelerates. Breaking this loop requires upstream intervention.

    Cannabinoid Protection: CBD and other cannabinoids have demonstrated: anti-inflammatory action (reduces SASP), antioxidant properties (protects telomeres from oxidative damage), potential telomerase upregulation via CB2 receptor activation, and neuroprotective effects. This is the scientific basis for cannabinoid RDI as upstream medicine.
    ~50-100bp
    Telomere loss/yr (normal)
    2-5x
    Accelerated with ACiD
    12,000bp
    Critical senescence threshold
    0.877
    THCA→THC decarb ratio

    Disease Prevalence (Millions Affected, US)

    Upstream Medicine vs Downstream Pharma

    ❌ DOWNSTREAM PHARMA MODEL Treat each disease AFTER it manifests:
    - Cancer → Chemotherapy/radiation ($100K-$1M+)
    - Diabetes → Insulin/GLP-1 ($1K-$15K/yr)
    - Obesity → Weight loss surgery/drugs ($15K-$25K)
    - Alzheimer's → Ineffective drugs ($5K+/yr)
    - Depression → SSRIs/side effects ($2K+/yr)
    - Chronic pain → Opioids (deadly cycle)
    Cost: $14.11T/yr. Does not address root cause.
    Outcome: Disease management, not healing.
    ✅ UPSTREAM MEDICINE (BN FLEET) Restore ECS + protect telomeres BEFORE disease manifests:
    - Cannabinoid nutrition (RDI) → restore ECS homeostasis
    - Remove artificial causes (toxins, bad diet, pharma)
    - TERT activation via anti-inflammatory nutrition
    - Break SASP feedback loop at cellular level
    - Body's innate healing capacity handles the rest
    Cost: Minimal (plant-based nutrition).
    Outcome: 90% disease reduction = $317T savings.
    This is the cannabinoid RDI thesis made actionable.

    The Upstream Solution — ECS Restoration Protocol

    Step 1: REMOVE artificial causes — Eliminate or reduce exposure to petrochemicals, pesticides, processed foods, fluoride, unnecessary pharmaceuticals.

    Step 2: RESTORE ECS function — Daily cannabinoid nutrition (RDI). Travis's protocol: 1,500mg CBD + 600mg THC in MCT oil daily. This is NUTRITION, not medication. The ECS needs cannabinoids like the body needs vitamin C.

    Step 3: PROTECT telomeres — Antioxidant-rich diet, reduced oxidative stress, anti-inflammatory lifestyle. Cannabinoids directly reduce the oxidative damage that shortens telomeres.

    Step 4: ACTIVATE healing — The body's innate regenerative capacity is UNLOCKED when the ECS is functioning. Stem cell mobilization, neurogenesis, immune rebalancing — all regulated by the ECS.

    Step 5: MEASURE & PROVE — BiGen evidence framework tracks outcomes. Flower Lab, Edible Tracker, Intake Tracker all feed session data. Meta-analysis validates the cannabinoid RDI thesis. The $317T savings hypothesis becomes evidence-based medicine.
    1,500mg
    CBD/day (RDI baseline)
    600mg
    THC/day (RDI baseline)
    5ml
    MCT carrier/day
    12 mo
    Target to heal 133M
    ACiD (Artificial Chronic Inflammatory Disease) is a theoretical framework proposed by Travis Remington, FMF HM3, MPAS PA, based on 20+ years of clinical observation. The TERT-ECS-telomere cascade hypothesis synthesizes peer-reviewed telomere biology, endocannabinoid system research, and oxidative stress/inflammation science. Individual claims range from [A] (well-established telomere biology) to [D] (practitioner-level clinical observation). The BN Fleet BiGen framework is designed to systematically validate each claim through consented data collection and meta-analysis. This is research, not medical advice. Consult qualified practitioners for individual health decisions.